You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.
 

 

CE

Identification and Management of Adverse Events in Cancer Immunotherapy: Practice Essentials for the Oncology Nurse

  • Authors: Joshua Bauml, MD; Susan McCall, MSN, ANP-BC, AOCNP; Victoria Sherry, DNP, CRNP, ANP-BC, AOCNP (Activity Chair)
  • CE Released: 8/24/2018
  • THIS ACTIVITY HAS EXPIRED
  • Valid for credit through: 8/24/2019
Start Activity


Target Audience and Goal Statement

This activity is intended for oncology nurses and other healthcare professionals who manage cancer patients receiving immune checkpoint inhibitors.

The goal of this activity is to discuss the importance of early identification and appropriate management of immune-related adverse events (irAEs) in cancer patients receiving immune checkpoint inhibitor therapy.

Upon completion of this activity, participants will be able to:

  1. Examine the clinical efficacy, unique response patterns, and safety profiles associated with immune checkpoint inhibitor therapy.
  2. Evaluate the signs and symptoms of immune-related adverse events (irAEs) associated with immune checkpoint inhibitors and understand how to differentiate these from other etiologies.
  3. Review recently published ASCO/NCCN guidelines for the management of irAEs and apply evidence-based recommendations to optimize patient care.


Disclosures

Disclosures

In accordance with the Food and Drug Administration, the speakers have disclosed that there is the potential for discussions concerning off-label uses of a commercial product/device during this educational activity.

Any person who may contribute to the content of this continuing education activity must disclose relevant relationships (and any known relationships of their spouse/partner) with commercial interests whose products or services are discussed in educational presentations. A commercial interest is defined as an entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on patients. Relevant relationships include receiving from a commercial interest research grants, consultant fees, travel, other benefits, or having a self-managed equity interest in a company.

Disclosure of a relationship is not intended to suggest or condone any bias in any presentation but is made to provide participants with information that might be of potential importance to their evaluation of a presentation.


Authors

  • Victoria Sherry, DNP, CRNP, ANP-BC, AOCNP (Activity Chair)

    Adult Oncology Nurse Practitioner for Thoracic Malignancies, Abramson Cancer Center, University of Pennsylvania Medical Center, Philadelphia, Pennsylvania

    Disclosures

    Disclosure: Victoria Sherry, DNP, CRNP, ANP-BC, AOCNP, has no relevant financial relationships to disclose in relation to the content of this activity.

  • Susan McCall, MSN, ANP-BC, AOCNP

    Research Nurse Practitioner, Lymphoma Service, Department of Nursing, Memorial Sloan Kettering Cancer Center, New York, New York

    Disclosures

    Disclosure: Susan McCall, MSN, ANP-BC, AOCNP, has no relevant financial relationships to disclose in relation to the content of this activity.

  • Joshua Bauml, MD

    Assistant Professor of Medicine, Division of Hematology/Oncology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania

    Disclosures

    Disclosure: Joshua Bauml, MD, has disclosed the following relevant financial relationships:
    Serves as a consultant for AstraZeneca Pharmaceuticals; Bristol-Myers Squibb Company; Boehringer Ingelheim Pharmaceuticals, Inc.; Celgene Corporation; Clovis Oncology, Inc.; Genentech, Inc.; Guardant Health; and Merck & Co., Inc.

    Institution receives grant/research support from Bayer Healthcare Pharmaceuticals, Inc.; Carevive Systems; Clovis Oncology, Inc.; Janssen Pharmaceuticals, Inc.; Merck & Co., Inc.; and Novartis Pharmaceuticals Corporation.

Nurse Reviewer

  • Stephanie Andrews, MS, ANP-BC

    Moffitt Cancer Center, Tampa, Florida

    Disclosures

    Disclosure: Stephanie Andrews, MS, ANP-BC, has disclosed the following relevant financial relationship: Serves on the speaker’s bureau for Genentech, Inc.

Planner

  • Adrienne Matson, PharmD, BCPS

    Creative Educational Concepts, Lexington, Kentucky

    Disclosures

    Disclosure: Adrienne Matson, PharmD, BCPS, has no relevant financial relationships to disclose in relation to the content of this activity.


Accreditation Statements


In support of improving patient care, Creative Educational Concepts is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    For Nurses

  • This activity is designated for 1.0 contact hours. Learners are advised that accredited status does not imply endorsement by the provider or ANCC of any commercial products displayed in conjunction with an activity. Upon successful completion of the post-test, statements of credit will be issued immediately and available for printing.

    Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]


Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive credit, you must receive a minimum score of 60% on the post-test.

Follow these steps to earn CME/CE credit*:

  1. Read the target audience, learning objectives, and author disclosures.
  2. Study the educational content online or printed out.
  3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.

CE

Identification and Management of Adverse Events in Cancer Immunotherapy: Practice Essentials for the Oncology Nurse

Authors: Joshua Bauml, MD; Susan McCall, MSN, ANP-BC, AOCNP; Victoria Sherry, DNP, CRNP, ANP-BC, AOCNP (Activity Chair)Faculty and Disclosures
THIS ACTIVITY HAS EXPIRED

CE Released: 8/24/2018

Valid for credit through: 8/24/2019

processing....

The slides from this presentation are considered intellectual property and for use as a professional resource. No content should be copied or reproduced in any manner for any reason.

 
  • Print